Insulin-like growth factor binding protein-4 expression is decreased by angiotensin II and thrombin in rat aortic vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 370-376

  Anwar, Asif ^a   Zahid, A A ^c   Phillips, L ^a,b   Delafontaine, P ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hop Cant Univ de Genève ^*

Author keywords

Angiotensin II; Gene expression; Insulin like growth factor binding proteins; Thrombin; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; DNA; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; THROMBIN;

ANIMAL CELL; AORTA; ARTICLE; BIOAVAILABILITY; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033970489     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.370     Document Type: Article

References (41)

1. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3-34.
2. Ververis JJ, Ku L, Delafontaine P. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ Res. 1993;72:1285-1292.
3. Delafontaine P, Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem. 1993; 268:16866-16870.
4. Delafontaine P, Anwar A, Lou H, Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest. 1996;97:139-145.
5. Delafontaine P, Meng XP, Ku L, Du J. Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides: effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. J Biol Chem. 1995;270: 14383-14388.
6. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990;66:1755-1760.
7. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation: evidence for local bioactivity. J Clin Invest. 1992; 90:1926-1931.
8. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res. 1995;30:825-834.
9. Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res. 1993;72:271-277.
10. Anwar A, Delafontaine P. Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta. Hypertension. 1994; 24:679-685.
11. Alexander RW, Brock TA, Gimbrone MA Jr, Rittenhouse SE. Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension. 1985;7:447-451.
12. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
13. Hossenlop P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like-growth-factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 1986;154:138-143.
14. Parker A, Gockerman A, Busby WH, Clemmons DR. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology. 1995;136:2470-2476.
15. Ververis J, Ku L, Delafontaine P. Fibroblast growth factor regulates insulin-like growth factor-binding protein production by vascular smooth muscle cells. Am J Med Sci. 1994;307:77-81.
16. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am. 1996;25:591-614.
17. Camacho-Hubner C, Busby WH, NcCusker RH, Wright G, Clemmons DR. Identifications of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem. 1992;267:11949-11956.
18. Conover CA, Clarkson JT, Bale LK. Phorbol ester tumor promotors regulate insulin-like growth factor-binding protein-4 proteolysis. Endocrinology. 1993;133:1347-1351.
19. Rees c, Clemmons DR, Horvitz GD, Clarke JB, Busby WH. A protease resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. Endocrinology. 1998;139:4182-4188.
20. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
21. Fath KA, Alexander RW, Delafontaine P. Hypertension modulates insulin-like growth factor I receptor mRNA levels. Circulation. 1991; 84(suppl II)):II-397. Abstract.
22. De Mellow JS, Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun. 1988;156:199-204.
23. Elgin RG, Busby WH, Clemmons DR. An insulin-like growth factor binding protein enhances the biological responses to IGF-I. Proc Acad Sci U S A. 1987;84:3313-3318.
24. Blum WF, Jenne EW, Reppin F, Keitzman K, Ranne MA, Bierich JR. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology. 1989;125:766-772.
25. Duan C, Clemmons DR. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. J Biol Chem. 1998;273:16836-16842.
26. Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP4 fusion gene induces smooth muscle hypoplasia. Endocrinology. 1998;135:2605-2614.
27. Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest. 1997;100:1425-1439.
28. Damon ES, Maddison L, Ware JL, Plymate SR. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. Endocrinology. 1998;139: 3456-3464.
29. Ceda GP, Fielder PJ, Henzel WJ, Louie A, Donovan SM, Hoffman AR, Rosenfeld RG. Differential effects of insulin-like growth factor (IGF)-I and II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. Endocrinology. 1991;128:2815-2824.
30. Camacho-Hubner C, McCusker RH, Clemmons DR. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. J Cell Physiol. 1991;148: 281-289.
31. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. Studies on regulation of insulin-like growth factor binding protein IGFBP-3 and IGFBP-4 production in human cells. Acta Endocrinol. 1992;127:555-564.
32. Giannella-Neto D, Kamyar A, Sharifi B, Pirola CJ, Kupfer J, Rosenfeld RG, Forrester JS, Fagin JA. Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ Res. 1992;71:646-656.
33. Cohick WS, Gockerman A, Clemmons DR. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor-binding proteins which are regulated differently by the insulin-like growth factors. J Cell Physiol. 1993;157:52-60.
34. McCusker RH, Clemmons DR. Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro. Endocrinology. 1994;134:2095-2102.
35. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
36. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
37. 2+ mobilization and protein kinase C activation. J Biol Chem. 1989;264:526-530.
38. Graham DJ, Alexander JJ. The effects of thrombin on bovine aortic endothelial and smooth muscle cells. J Vasc Surg. 1990;11:307-313.
39. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
40. Stouffer GA, Runge MS. The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells. Semin Thromb Hemost. 1998;24:145-150.
41. Molloy CJ, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist. J Clin Invest. 1996;97:1173-1183.